Prostate Cancer - Oct 29, 2017 Edition

October 29, 2017     Prostate Cancer     The latest prostate cancer news from News Medical

What men need to know: Prevention, diagnosis, and treatment of prostate cancer   Prostate cancer is the second leading cause of cancer death in men. Next to skin cancers, prostate cancer is the most common cancer diagnosed in American men.       Preference for preserving sexual function not strongly reflected in prostate cancer treatment choices   Preserving sexual function was important to many men facing treatment for prostate cancer, according to a recent study by University of North Carolina Lineberger Comprehensive Cancer Center researchers. However, this preference was not strongly reflected in the treatment choices of men with low-risk prostate cancer.

Queen's University Belfast leads new research to better understand biology of prostate cancer   Queen's University Belfast has led the world's largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumors, which could lead to a transformation in how prostate cancer is diagnosed and treated.         Common factors that could change your PSA test results   Most men in their 50s, who face an increasing risk of prostate cancer as they age, are familiar with the common screening exam known as the prostate specific antigen (PSA) test. But many are less familiar with how the test works and why different factors, such as prescription medications and infections, can influence the test results.

MUSC and SCSU join forces to address health disparities   Marvella Ford missed out on a fundamental part of childhood: having grandparents to spoil and take care of her. They all died before she was born. "That's a tremendous loss that you can never overcome. I grew up not having met or seen pictures of any of my grandparents," she said.       Sleeper cells in cancerous tumors can be destroyed if they possess specific defects   In many metastasized types of cancer, disseminated tumors grow back despite successful chemotherapy. As a research team under the direction of the University of Bern, Switzerland, has now discovered, this is because of isolated cancer cells that survive the chemotherapy due to a phase of dormancy.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK